Invesco Ltd. Rocket Pharmaceuticals, Inc. Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 352,622 shares of RCKT stock, worth $4.93 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

352,622

Previous 352,026 0.17%

Holding current value

$4.93 Million

Previous $7.58 Million 14.08%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$17.6 - $25.88 $10,489 - $15,424	596 Added 0.17%	352,622 $6.51 Million
Q2 2024 Aug 13, 2024	BUY	$20.66 - $26.72 $6.42 Million - $8.31 Million	310,836 Added 754.64%	352,026 $7.58 Million
Q1 2024 May 14, 2024	SELL	$26.16 - $30.74 $1.46 Million - $1.71 Million	-55,653 Reduced 57.47%	41,190 $1.11 Million
Q4 2023 Feb 12, 2024	BUY	$16.78 - $31.94 $720,113 - $1.37 Million	42,915 Added 79.58%	96,843 $2.9 Million
Q3 2023 Nov 13, 2023	SELL	$15.07 - $24.05 $1.55 Million - $2.48 Million	-103,151 Reduced 65.67%	53,928 $1.1 Million
Q2 2023 Aug 11, 2023	BUY	$16.59 - $23.6 $1.93 Million - $2.74 Million	116,284 Added 285.04%	157,079 $3.12 Million
Q1 2023 May 12, 2023	SELL	$15.79 - $22.6 $1.07 Million - $1.53 Million	-67,582 Reduced 62.36%	40,795 $698,000
Q4 2022 Feb 13, 2023	BUY	$15.5 - $22.76 $1.13 Million - $1.66 Million	72,819 Added 204.79%	108,377 $2.12 Million
Q3 2022 Nov 14, 2022	SELL	$12.37 - $18.41 $15,153 - $22,552	-1,225 Reduced 3.33%	35,558 $567,000
Q2 2022 Aug 15, 2022	BUY	$7.96 - $16.64 $12,162 - $25,425	1,528 Added 4.33%	36,783 $506,000
Q1 2022 May 16, 2022	BUY	$13.16 - $23.68 $220,416 - $396,616	16,749 Added 90.51%	35,255 $558,000
Q4 2021 Feb 14, 2022	SELL	$21.52 - $36.02 $61,310 - $102,620	-2,849 Reduced 13.34%	18,506 $405,000
Q3 2021 Nov 15, 2021	SELL	$27.42 - $48.97 $4.84 Million - $8.64 Million	-176,462 Reduced 89.2%	21,355 $638,000
Q2 2021 Aug 17, 2021	SELL	$39.41 - $47.25 $3.31 Million - $3.97 Million	-83,957 Reduced 29.8%	197,817 $8.76 Million
Q1 2021 May 17, 2021	SELL	$43.34 - $65.91 $11.2 Million - $17 Million	-258,294 Reduced 47.83%	281,774 $12.5 Million
Q4 2020 Feb 16, 2021	BUY	$23.3 - $59.57 $2.81 Million - $7.19 Million	120,643 Added 28.76%	540,068 $29.6 Million
Q3 2020 Nov 16, 2020	BUY	$20.5 - $28.59 $15,744 - $21,957	768 Added 0.18%	419,425 $9.59 Million
Q2 2020 Aug 14, 2020	SELL	$13.32 - $22.61 $2.17 Million - $3.68 Million	-162,647 Reduced 27.98%	418,657 $8.76 Million
Q1 2020 May 15, 2020	SELL	$9.71 - $25.11 $30,042 - $77,690	-3,094 Reduced 0.53%	581,304 $8.11 Million
Q4 2019 Feb 14, 2020	SELL	$11.07 - $24.23 $60,597 - $132,635	-5,474 Reduced 0.93%	584,398 $13.3 Million
Q2 2019 Aug 14, 2019	BUY	$15.0 - $19.81 $60 - $79	4 Added 0.0%	589,872 $8.85 Million
Q1 2019 May 15, 2019	SELL	$13.45 - $19.01 $4,936 - $6,976	-367 Reduced 0.06%	589,868 $10.3 Million
Q4 2018 Feb 14, 2019	BUY	$11.21 - $23.53 $6.62 Million - $13.9 Million	590,235 New	590,235 $8.75 Million

Others Institutions Holding RCKT

# of Institutions

209

Shares Held

93.2M

Call Options Held

319K

Put Options Held

70.3K

View Full List

About ROCKET PHARMACEUTICALS, INC.

Ticker RCKT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 75,683,696
Market Cap $1.06B
Description
Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...

More about RCKT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account